View in EDS

Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Comprehensive Exposure-Response Analysis of the DREAMM-8 Study.

Saved in:
Bibliographic Details
Title: Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Comprehensive Exposure-Response Analysis of the DREAMM-8 Study.
Authors: Hanafin P; GSK, 1250 S Collegeville Rd, Collegeville, PA, 19426, USA., Ho YL; GSK, 1250 S Collegeville Rd, Collegeville, PA, 19426, USA., Papathanasiou T; GSK, Baar, Switzerland., Fulci G; GSK, Waltham, MA, USA., Sule N; GSK, 1250 S Collegeville Rd, Collegeville, PA, 19426, USA., Kremer BE; GSK, 1250 S Collegeville Rd, Collegeville, PA, 19426, USA., Ferron-Brady G; GSK, 1250 S Collegeville Rd, Collegeville, PA, 19426, USA. geraldine.x.ferron@gsk.com.
Source: Targeted oncology [Target Oncol] 2025 Sep; Vol. 20 (5), pp. 833-845. Date of Electronic Publication: 2025 Sep 16.
Publication Type: Journal Article; Clinical Trial, Phase III; Multicenter Study; Randomized Controlled Trial
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40958065
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Comprehensive Exposure-Response Analysis of the DREAMM-8 Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hanafin+P%22">Hanafin P</searchLink>; GSK, 1250 S Collegeville Rd, Collegeville, PA, 19426, USA.<br /><searchLink fieldCode="AU" term="%22Ho+YL%22">Ho YL</searchLink>; GSK, 1250 S Collegeville Rd, Collegeville, PA, 19426, USA.<br /><searchLink fieldCode="AU" term="%22Papathanasiou+T%22">Papathanasiou T</searchLink>; GSK, Baar, Switzerland.<br /><searchLink fieldCode="AU" term="%22Fulci+G%22">Fulci G</searchLink>; GSK, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sule+N%22">Sule N</searchLink>; GSK, 1250 S Collegeville Rd, Collegeville, PA, 19426, USA.<br /><searchLink fieldCode="AU" term="%22Kremer+BE%22">Kremer BE</searchLink>; GSK, 1250 S Collegeville Rd, Collegeville, PA, 19426, USA.<br /><searchLink fieldCode="AU" term="%22Ferron-Brady+G%22">Ferron-Brady G</searchLink>; GSK, 1250 S Collegeville Rd, Collegeville, PA, 19426, USA. geraldine.x.ferron@gsk.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101270595%22">Targeted oncology</searchLink> [Target Oncol] 2025 Sep; Vol. 20 (5), pp. 833-845. <i>Date of Electronic Publication: </i>2025 Sep 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Multicenter Study; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer-Verlag+France%22">Springer-Verlag France </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>101270595 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1776-260X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217762596%22">17762596 </searchLink><i>NLM ISO Abbreviation: </i>Target Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40958065
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11523-025-01174-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 833
    Titles:
      – TitleFull: Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Comprehensive Exposure-Response Analysis of the DREAMM-8 Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hanafin P
      – PersonEntity:
          Name:
            NameFull: Ho YL
      – PersonEntity:
          Name:
            NameFull: Papathanasiou T
      – PersonEntity:
          Name:
            NameFull: Fulci G
      – PersonEntity:
          Name:
            NameFull: Sule N
      – PersonEntity:
          Name:
            NameFull: Kremer BE
      – PersonEntity:
          Name:
            NameFull: Ferron-Brady G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2025 Sep
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1776-260X
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Targeted oncology
              Type: main
ResultId 1